S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
NASDAQ:AMHC

Amplitude Healthcare Acquisition Stock Forecast, Price & News

$15.12
0.00 (0.00 %)
(As of 09/24/2021)
Add
Compare
Today's Range
$12.64
▼
$15.80
50-Day Range
$9.93
▼
$15.12
52-Week Range
$9.80
▼
$15.80
Volume2.25 million shs
Average Volume128,744 shs
Market Capitalization$189 million
P/E RatioN/A
Dividend YieldN/A
Beta0.11
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive AMHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Amplitude Healthcare Acquisition and its competitors with MarketBeat's FREE daily newsletter.


Amplitude Healthcare Acquisition logo

About Amplitude Healthcare Acquisition

Amplitude Healthcare Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to focus on the life sciences and pharmaceutical services sectors in the United States and Europe. Amplitude Healthcare Acquisition Corporation was incorporated in 2019 and is based in New York, New York.

Headlines

Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy
September 24, 2021 |  finance.yahoo.com
Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Two New Board Members
September 20, 2021 |  finance.yahoo.com
Jasper Therapeutics To List On NASDAQ Via SPAC Reverse Merger
May 6, 2021 |  finance.yahoo.com
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Amplitude Healthcare Acquisition Corporation (Nasdaq – AMHC)
May 6, 2021 |  finance.yahoo.com
BRIEF-Jasper Therapeutics And Amplitude Healthcare Acquisition Announce Merger
May 6, 2021 |  msn.com
Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
May 6, 2021 |  finance.yahoo.com
Amplitude Launches the Industry’s First Digital Optimization Ecosystem
April 28, 2021 |  in.finance.yahoo.com
What Is The Ownership Structure Like For Amplitude Healthcare Acquisition Corporation (NASDAQ:AMHC)?
March 5, 2021 |  finance.yahoo.com
Medical Fiber Optics Market Size to Reach US$ 1,531.9 Million by 2030
February 24, 2021 |  marketwatch.com
Amplitude Healthcare Acquisition Corp. Cl A
December 18, 2020 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AMHC
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
N/A
Phone
N/A
Employees
3
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.40 per share
Price / Book
37.80

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
$-590,000.00
Net Margins
N/A
Return on Equity
66.84%
Return on Assets
3.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.29
Quick Ratio
1.29

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
12,500,000
Market Cap
$189 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

0.33 out of 5 stars

Medical Sector

1304th out of 1,361 stocks

Biological Products, Except Diagnostic Industry

193rd out of 196 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Amplitude Healthcare Acquisition (NASDAQ:AMHC) Frequently Asked Questions

What stocks does MarketBeat like better than Amplitude Healthcare Acquisition?

Wall Street analysts have given Amplitude Healthcare Acquisition a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Amplitude Healthcare Acquisition wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Amplitude Healthcare Acquisition's key executives?

Amplitude Healthcare Acquisition's management team includes the following people:
  • Mr. Balaji Venkataraman, CEO & Director (Age 53)
  • Mr. Vishal Kapoor, Pres (Age 46)
  • Mr. Kenneth F. Clifford, Chief Financial Officer (Age 65)

What is Amplitude Healthcare Acquisition's stock symbol?

Amplitude Healthcare Acquisition trades on the NASDAQ under the ticker symbol "AMHC."

How do I buy shares of Amplitude Healthcare Acquisition?

Shares of AMHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Amplitude Healthcare Acquisition's stock price today?

One share of AMHC stock can currently be purchased for approximately $15.12.

How much money does Amplitude Healthcare Acquisition make?

Amplitude Healthcare Acquisition has a market capitalization of $189 million.

How many employees does Amplitude Healthcare Acquisition have?

Amplitude Healthcare Acquisition employs 3 workers across the globe.

Where are Amplitude Healthcare Acquisition's headquarters?

Amplitude Healthcare Acquisition is headquartered at 1177 AVENUE OF THE AMERICAS FL 40, NEW YORK NY, 10036.


This page was last updated on 10/18/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.